Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Maternal ABO blood group and adverse pregnancy outcomes

Journal of Perinatology volume 33, pages 107–111 (2013)Cite this article

Subjects

Abstract

Objective:

To determine the relationship between maternal ABO blood group and risk of adverse pregnancy outcomes.

Study Design:

Data on ABO phenotypes and pregnancy outcomes were collected from medical records of 5320 singleton pregnant women who had ABO blood testing and follow-up care until delivery in our institution. Adverse pregnancy outcomes that were studied in relation to maternal blood group included preeclampsia, gestational diabetes mellitus (GDM), preterm delivery, low birth weight (LBW) and small for gestational age (SGA) infants.

Result:

Out of 5320 women, 350 (6.6%), 333 (6.3%) and 543 (10.2%) women were diagnosed with preeclampsia, GDM and preterm delivery, respectively. LBW and SGA were, respectively, observed in 394 (7.4%) and 178 (3.3%) infants. By uni- and multivariable analyses, women with A or AB blood types, but not B, were found at increased risk of preeclampsia compared with O type individuals; adjusted relative risks were 1.7 (95% confidence interval (CI), 1.3 to 2.3; P=0.001) for A phenotype and 1.7 (95% CI, 1.1 to 2.6; P=0.01) for AB phenotype. There were no significant relationships between blood types and GDM, preterm delivery, LBW or SGA.

Conclusion:

Maternal ABO blood group was associated with the risk of preeclampsia, but not with GDM, preterm delivery, LBW or SGA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Storry JR, Olsson ML . The ABO blood group system revisited: a review and update. Immunohematology 2009; 25: 48–59.

    CAS  PubMed  Google Scholar 

  2. Storry JR . Human blood groups: inheritance and importance in transfusion medicine. J Infus Nurs 2003; 26: 367–372.

    Article  Google Scholar 

  3. Reid ME, Mohandas N . Red blood cell blood group antigens: structure and function. Semin Hematol 2004; 41: 93–117.

    Article  CAS  Google Scholar 

  4. Yip SP . Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles. Blood 2000; 95: 1487–1492.

    CAS  PubMed  Google Scholar 

  5. Oriol R, Candelier JJ, Mollicone R . Molecular genetics of H. Vox Sang 2000; 78 (Suppl 2): 105–108.

    CAS  PubMed  Google Scholar 

  6. Garratty G . Blood groups and disease: a historical perspective. Transfus Med Rev 2000; 14: 291–301.

    Article  CAS  Google Scholar 

  7. Smith AW, Aathithan S, Power EG, Abdulla Y . Blood group antigens and Helicobacter pylori infections. Lancet 1994; 343: 543.

    Article  CAS  Google Scholar 

  8. O’Donnell J, Laffan MA . The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001; 11: 343–351.

    Article  Google Scholar 

  9. Aird I, Bentall HH, Roberts JA . A relationship between cancer of the stomach and the ABO blood groups. Br Med J 1953; 1: 799–801.

    Article  CAS  Google Scholar 

  10. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008; 4: e1000072.

    Article  Google Scholar 

  11. Paré G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6578 women. PLoS Genet 2008; 4: e1000118.

    Article  Google Scholar 

  12. Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T et al. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study. Thromb Res 2009; 124: 167–173.

    Article  CAS  Google Scholar 

  13. May D . Letter: maternal blood group A and pre-eclampsia. Br Med J 1973; 4: 738.

    Article  CAS  Google Scholar 

  14. Spinillo A, Capuzzo E, Baltaro F, Piazzi G, Iasci A . Case-control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens 1995; 9: 623–625.

    CAS  PubMed  Google Scholar 

  15. Clark P, Walker ID, Govan L, Wu O, Greer IA . The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140: 236–240.

    PubMed  Google Scholar 

  16. Donma MM . Macrosomia, top of the iceberg: the charm of underlying factors. Pediatr Int 2011; 53: 78–84.

    Article  Google Scholar 

  17. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia: number 33, January 2002. Obstet Gynecol 2002; 99: 159–167.

    Google Scholar 

  18. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27 (Suppl 1): S88–S90.

    Google Scholar 

  19. Thaithamyanont P, Bhongvej S, Chittinond S . Intrauterine growth in Thai population. J Pediatr Soc Thai 1984; 23: 99–105.

    Google Scholar 

  20. Racial & ethnic distribution of ABO blood types. Available at: http://www.bloodbook.com/world-abo.html, Retrieved 9 February 2012.

  21. Wiwanitkit V . ABO blood group of the Thais in Bangkok. Songkla Med J 2001; 19: 9–12.

    Google Scholar 

  22. Jenkins PV, O’Donnell JS . ABO blood group determines plasma von Willebrand factor levels: a biological function after all? Tranfusion 2006; 46: 1836–1844.

    Article  CAS  Google Scholar 

  23. Nadar SK, Al Yemeni E, Blann AD, Lip GY . Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. Thromb Res 2004; 113: 123–128.

    Article  CAS  Google Scholar 

  24. Parra-Cordero M, Bosco C, González J, Gutiérrez R, Barja P, Rodrigo R . Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta. J Mol Histol 2011; 42: 459–465.

    Article  CAS  Google Scholar 

  25. Deng L, Bremme K, Hansson LO, Blombäck M . Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994; 84: 941–945.

    CAS  PubMed  Google Scholar 

  26. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010; 19: 1856–1862.

    Article  CAS  Google Scholar 

  27. Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G . Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediators Inflamm 2010; 2010: 908649.

    Article  CAS  Google Scholar 

  28. Szarka A, Rigó Jr J, Lázár L, Beko G, Molvarec A . Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010; 11: 59.

    Article  CAS  Google Scholar 

  29. Chavarría ME, Lara-González L, García-Paleta Y, Vital-Reyes VS, Reyes A . Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol 2008; 137: 157–164.

    Article  Google Scholar 

  30. Puangsricharern A, Suksawat S . Prevalence of Rh negative pregnant women who attended the antenatal clinic and delivered in Rajavithi Hospital: 2000-2005. J Med Assoc Thai 2007; 90: 1491–1494.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, University of Bangkok Metropolis, Bangkok, Thailand

    C Phaloprakarn & S Tangjitgamol

Authors
  1. C Phaloprakarn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Tangjitgamol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Phaloprakarn.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phaloprakarn, C., Tangjitgamol, S. Maternal ABO blood group and adverse pregnancy outcomes. J Perinatol 33, 107–111 (2013). https://doi.org/10.1038/jp.2012.73

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2012.73

Keywords

This article is cited by

Search

Advanced search

Quick links